High levels of loss at the 17p telomere suggest the close proximity of a tumour suppressor

British Journal of Cancer

Volumn 74, Issue 6, 1996, Pages 863-870

  White, Grm ^a   Stack, M ^b   Santibanez Koref M ^c   Liscia, D S ^d   Venesio, T ^d   Wang, J C ^e   Helms, C ^e   Donis Keller, H ^e   Betticher, D C ^f   Altermatt, H J ^f   Hoban, P R ^a   Heighway, J ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d MOLINETTE HOSPITAL   (Italy)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF BERN   (Switzerland)

Author keywords

Breast cancer; Chromosome 17; Loss of heterozygosity; Lung cancer

Indexed keywords

ARTICLE; BREAST CANCER; CHROMOSOME 17P; CONTROLLED STUDY; FEMALE; HETEROZYGOSITY; HUMAN; LUNG CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TELOMERE; TUMOR SUPPRESSOR GENE; YEAST ARTIFICIAL CHROMOSOME;

EID: 10144238997     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.449     Document Type: Article

References (30)

1. BAKER SJ, FEARON ER, NIGRO JM, HAMILTON SR, PREISINGER AC, JESSUP JM, VAN TUINEN P, LEDBETTER DH, BARKER DF, NAKAMLRA Y, WHITE R AND VOGELSTEIN B. (1989). Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science, 244, 217-221.
2. BETTICHER DC, HEIGHWAY J, HASELTON PS, ALTERMATT HJ, RYDER WDJ, CERNY T AND THATCHER N. (1996). Prognostic significance of CCNDl (cyclin Dl) overexpression in lung cancer. Br. J. Cancer, 73, 294-300.
3. BROWNE, DL, SMITH BA, DIETZ-BAND J, RIETHMANN HC, PHROMCHOTIKUL T AND LITT M. (1995). Dinucleotide repeat polymorphism at the human chromosome 11p telomere (D11S2071) Genomics, 25, 600-601.
4. CALL KM, GLASER T, ITO CY, BUCKLER AJ, PELLETIER J, HABER DA, ROSE EA, KRAL A, YEGER H, LEWIS WH, JONES C AND HOUSMAN DE. (1990). Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumour locus. Cell, 60, 509-520.
5. CHIBA I, TAKAHASHI T, NAU MM, D'AMICO D, CURIEL DT, MITSUDOMI T, BUCHHAGEN DL, CARBONE D, PIANTADOSI S, KOGA H, RElSSMAN PT, SLAMON DJ, HOLMES EC AND MINNA JD. (1990). Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene, 5, 1603-1610.
6. COLES C, THOMPSON AM, ELDER PA, COHEN BB, MACKENZIE IM, CRANSTON G, CHETTY U, MACKAY J, MACDONALD M, NAKAMURA Y, HOYHEIM B AND STEEL CM. (1990). Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet, 336, 761.
7. CORNELIS RS, VAN VLIET M, VOS CBJ, CLETON-JANSEN A-M, VAN DE VIJVER MJ, PETERSE JL, KHAM M, BØRRESEN A-L, CORNELISSE CJ AND DEVILEE P. (1994). Evidence for a gene on 17p13.3, distal to TP53 as a target for allele loss in breast tumours without p53 mutations. Cancer Res., 54, 4200-4206.
8. FOULKES WD, BLACK DM, STAMP GHM, SOLOMON E AND TROWSDALE J. (1993). Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma. Int. J. Cancer, 54, 220-225.
9. FRIEJE D, HELMS C, WATSON MS AND DONIS-KELLER H. (1992). Identification of a second autosomal region near the Xq and Yq telomeres. Science, 258, 1784-1787.
10. GERKEN SC, ALBERTSEN H, ALSNER T, BALLARD L, HOLIK P, LAWRENCE E, MOORE M, ZHAO X AND WHITE R. (1995). A strategy for constructing high-resolution genetic maps of the human genome: a genetic map of chromosome 17p, ordered with meiotic breakpoint-mapping panels. Am. J. Hum. Genet., 56, 484-499.
11. GYAPAY G, MORISSETTE J, VIGNAL A, DIB C, KIZAMES C, MILLASSEAU P, MARC S, BERNADI G, LATHROP M AND WEISSENBACH J. (1994). The 1993-94 Généthon human genetic linkage map. Nature Genet., 7, 246-339.
12. HIYAMA K, ISHIOKA S, SHIROTANI Y, INAI K, HIYAMA E, MURAKAMI I, ISOBE T, INAMIZU T AND YAMAKlDO M. (1995). Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogene, 10, 937-944.
13. HULTMAN T, STÅHL S, HORNES E AND UHLÉN M. (1989). Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucleic Acids Res., 17, 4937-4946.
14. JONES MH AND NAKAMURA Y, (1992). Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide reneat nolvmorphism Genes Chrom Cancer 5 89-90
15. JOSLYN J, CARLSON M, THLIVERIS A, ALBERTSEN H, GELBERT L, SAMOWITZ W, GRODEN J, STEVENS J, SPIRIO L, ROBERTSON M, SARGEANT L, CRAPCHO K, WOLFF E, BURT R, HUGHES JP, WARRINGTON J, WASMUTH J, LE PASLIEF D, ABDERRAHIM H, COHEN D, LEPPERT M AND WHITE R. (1991). Identification of deletion mutants and three new genes at the familial polyposis locus. Cell, 66, 601-613.
16. MELTZER PS, GVAN XY AND TRENT JM. (1993). Telomere capture stabilizes chromosome breakage. Nature Genet., 4, 252-255.
17. MERLO GR, VENESIO T, BERNARDI A, CROPP CS, DIELLA F, CAPPA APM, LISCIA DS AND CALLAHAN R. (1994). Evidence for a second tumour suppressor gene on 17p linked to high S-phase index in primary human breast carcinomas. Cancer Genet. Cytogenet., 76, 106-111.
18. MIKI Y, SWENSEN J, SHATTUCK-EIDENS D, FUTREAL PA, HARSHMAN K, TAVTIGIAN S, LIU Q, COCHRAN C, BENNET LM, DING W, BELL R, ROSENTHAL J, HUSSEY C, TRAN T, MCCLURE M, FRYE C, HATTIER T, PHELPS R, HAUGEN-STRANO A, KATCHER H, YAKUMO K, GHOLAMI Z, SHAFFER D, STONE S, BAYER S, WRAY C, BOGDEN R, DAYANANTH P, WARD J, TONIN P, NAROD S, BRISTOW PK, NORRIS FH, HELVERING L, MORRISON P, ROSTECK P, LAI M, BARRET JC, LEWIS C, NEUHAUSEN S, CANNON-ALBRIGHT L, GOLDGAR D, WISEMAN R, KAMB A AND SKOLNICK MH. (1994). A strong candidate gene for the breast and ovarian cancer susceptibility gene. Science, 266, 66-71.
19. MITSUDOMI T, STEINBERG SM, NAU MM, CARBONE D. D'AMICO D, BODMER S, OIE HK, LINNOILA RI, MULSHINE JL, MINNA JD AND GAZDAR AF. (1992). P53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene, 7, 171-180.
20. ORPHANUS V, MCGOWN G, BOYLE JM AND SANTIBANEZ-KOREF M.(1993). Thirteen dinucleotide repeat polymorphisms on human chromosome 6. Hum. Mol. Genet., 2, 2196.
21. PANDIT SD, WANG JC, VEILE RA, MISHRA SK, WARLICK CA AND DONIS-KELLER H. (1995). Index, comprehensive microsatellite and unified linkage maps of human chromosome 14 with cytogenetic tie points and a telomere microsatellite marker. Genomics, 29, 653-664.
22. PROSSER J, THOMPSON AM, GRANSTON G AND EVANS HJ. (1990). Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours. Oncogene, 5, 1573-1579.
23. RILEY JH, BUTLER R, OGILVIE D, FINNIEAR R, JENNER D, POWELL S ANAND R, SMITH JC. AND MARKHAM AF. (1990). A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosomes (YAC) clones. Nucleic Acids Res., 18, 2887-2890.
24. SAMBROOK J, FRITSCH EF AND MANIATIS T. (1989). Molecular Cloning: A Laboratory Manual 2nd edition. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, USA.
25. SHEN Y, KOZMAN HM, THOMPSON A, PHILIPS HA, HOLMAN K, NANCARROW J, LANE S, CHEN LZ, APOSTOLOU S, DOGGET NA, CALLEN DF, MULLEY JC, SUTHERLAND GR AND RICHARDS RI. (1994). A PCR based linkage map of human chromosome 16. Genomics, 22, 68-76.
26. STACK M, CRICHTON D AND SANTIBANEZ-KOREF MF. (1994). Two dinucleotide repeat polymorphisms at 17p13. Hum. MoL. Genet., 3, 1443.
27. STACK M, JONES D, WHITE G, LISCIA DS, VENESIO T, CASEY G, CRICHTON D, VARLEY J, MITCHKLL E, HEIGHWAY J AND SANTIBÁNEZ-KOREF M. (1995). Detailed mapping and loss of heterozygosity analysis suggests a suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13.3. Hum. Mol. Genet., 4, 2047-2055.
28. VOCERO AKBANI A, HELMS C, WANG JC, SANJURJO FJ, KORTESAREATY J, VEILE RA, LIU L, JAUCH A, CREMER T, BURGESS AK, HING AV, HOLT MS, RAMACHANDRA S, WHELAN AJ, ANKER R, AHRENT L, CHEN M, GAVIN MR, IANNANTUONI K, MORTON SM, PANDIT SD, READ CM, STEINBRUECK T, WARLlCK C, SMOLLER DA AND DONIS-KELLER H. (1996). Mapping human telomere regions with YAC and Pl clones: chromosome specific markers for 27 telomeres including 147 STSs and 24 polymorphisms for 14 proterminal regions. Genomics, (submitted).
29. WEINBERG RA. (1990). The retinoblastoma gene and cell growth control. Trends Biachem. Sci., 15, 199-202.
30. WILLIAMSON MP, ELDER PA, SHAW ME, DEVLIN J AND KNOWLES MA. (1995). p16(CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum. Mol. Genet., 4, 1569-1577.